UNSPSC 51333512: Pridinol hydrochloride

This classification denotes an antipsychotic agent C20H25NO.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3HI2Q2Y868, chemically known as 1,1-diphenyl-3-(piperidin-1-yl)propan-1-ol hydrochloride, but more generally known as pridinol hydrochloride, which bears US NIH Compound Identifier 71595. European Medicines Agency schedules Pridinol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04035MIG.

Most nations, for tariff and trade purposes, schedule pridinol hydrochloride under HS 29333999 and SITC 51574. As of Q4 2014, PRIDINOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: C1CCC(CC1)C(CCN2CCCCC2)(C3CCCCC3)O.CL.

UNSPSC 51333512 Pridinol hydrochloride is a Commodity code that in current state and local procurement practice does not map to a coherent buying pattern. The recent opportunities posted under this code span naloxone distribution, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals—none of which target pridinol hydrochloride specifically. The code appears to be a misalignment between the taxonomy label and the actual procurement activity, suggesting that state and local agencies are tagging pharmaceutical acquisitions at a higher or adjacent code level rather than at this specific substance commodity.

The three most recent state and local opportunities show activity across Florida, Texas, and Minnesota. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually (due July 26, 2023). Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a direct-to-manufacturer prescription program. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, released RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local government facilities including Oregon, with a response deadline of March 26, 2026. Because the recent solicitations do not target pridinol hydrochloride, the code shows little relevant procurement activity for vendors seeking to supply this substance specifically.